Protagonist Therapeutics Stock Target Price and Analyst Consensus

PTGX Stock  USD 28.48  0.48  1.71%   
The current analyst and expert consensus on Protagonist Therapeutics is Strong Buy, with 3 strong buy opinions. The current projected Protagonist Therapeutics target price consensus is 40.75 with 6 analyst opinions. The most common way Protagonist Therapeutics analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview Protagonist Therapeutics executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on Protagonist Therapeutics. We strongly encourage you to use your own analysis of Protagonist Therapeutics to validate this buy or sell advice. Protagonist Therapeutics buy-or-sell recommendation module provides average expert sentiment on the projected Protagonist Therapeutics target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on Protagonist Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.
Lowest Forecast
37.08
Highest Forecast
45.23
Target Price
40.75
Gross Profit is likely to rise to about 59.5 M in 2024, whereas Pretax Profit Margin is likely to drop (1.38) in 2024. At this time, Protagonist Therapeutics' Long Term Debt is fairly stable compared to the past year. Capital Surpluse is likely to rise to about 908.9 M in 2024, whereas Total Assets are likely to drop slightly above 204.1 M in 2024.
  
It's important to approach Protagonist Therapeutics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.

Protagonist Therapeutics Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Protagonist target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Protagonist Therapeutics' target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   6  Strong Buy
Most Protagonist analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Protagonist stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Protagonist Therapeutics, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Protagonist Therapeutics Target Price Projection

Protagonist Therapeutics' current and average target prices are 28.48 and 40.75, respectively. The current price of Protagonist Therapeutics is the price at which Protagonist Therapeutics is currently trading. On the other hand, Protagonist Therapeutics' target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Protagonist Therapeutics Market Quote on 28th of March 2024

Low Price27.94Odds
High Price28.62Odds

28.48

Target Price

Analyst Consensus On Protagonist Therapeutics Target Price

Low Estimate37.08Odds
High Estimate45.23Odds

40.75

Historical Lowest Forecast  37.08 Target Price  40.75 Highest Forecast  45.23
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Protagonist Therapeutics and the information provided on this page.

Protagonist Therapeutics Analyst Ratings

Protagonist Therapeutics' analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Protagonist Therapeutics stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Protagonist Therapeutics' financials, market performance, and future outlook by experienced professionals. Protagonist Therapeutics' historical ratings below, therefore, can serve as a valuable tool for investors.

Analyst Consensus Breakdown

Average Consensus Estimates

Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize Protagonist Therapeutics price targets

Protagonist Therapeutics' stock target price is an estimate of its future price, usually made by analysts. Using Protagonist Therapeutics' target price to determine if it is a suitable investment can be done through the following steps:
  • Look at Protagonist Therapeutics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Protagonist Therapeutics' stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional Protagonist Therapeutics Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Protagonist Therapeutics is a key component of Protagonist Therapeutics valuation and have some predictive power on the future returns of a Protagonist Therapeutics.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Protagonist Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
25.3429.1632.98
Details
Intrinsic
Valuation
LowRealHigh
28.2732.0935.91
Details
Naive
Forecast
LowNextHigh
24.0927.9131.73
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.622.224.58
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Protagonist Therapeutics. Your research has to be compared to or analyzed against Protagonist Therapeutics' peers to derive any actionable benefits. When done correctly, Protagonist Therapeutics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Protagonist Therapeutics.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Corona Opportunity Idea
Corona Opportunity
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested a lot of shares
Business Services Idea
Business Services
Invested over 100 shares
When determining whether Protagonist Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Protagonist Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Protagonist Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Protagonist Therapeutics Stock:
Check out Macroaxis Advice on Protagonist Therapeutics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more information on how to buy Protagonist Stock please use our How to Invest in Protagonist Therapeutics guide.
Note that the Protagonist Therapeutics information on this page should be used as a complementary analysis to other Protagonist Therapeutics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Funds Screener module to find actively-traded funds from around the world traded on over 30 global exchanges.

Complementary Tools for Protagonist Stock analysis

When running Protagonist Therapeutics' price analysis, check to measure Protagonist Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Protagonist Therapeutics is operating at the current time. Most of Protagonist Therapeutics' value examination focuses on studying past and present price action to predict the probability of Protagonist Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Protagonist Therapeutics' price. Additionally, you may evaluate how the addition of Protagonist Therapeutics to your portfolios can decrease your overall portfolio volatility.
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Global Correlations
Find global opportunities by holding instruments from different markets
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
The data published in Protagonist Therapeutics' official financial statements usually reflect Protagonist Therapeutics' business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Protagonist Therapeutics. For example, before you start analyzing numbers published by Protagonist accountants, it's critical to develop an understanding of what Protagonist Therapeutics' liquidity, profitability, and earnings quality are in the context of the Biotechnology space in which it operates.
Please note, the presentation of Protagonist Therapeutics' financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Protagonist Therapeutics' management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Protagonist Therapeutics' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Protagonist Therapeutics. Please utilize our Beneish M Score to check the likelihood of Protagonist Therapeutics' management manipulating its earnings.